Sono-Tek (NASDAQ:SOTK – Get Free Report) issued its quarterly earnings results on Wednesday. The industrial products company reported $0.02 earnings per share for the quarter, missing analysts’ consensus estimates of $0.04 by ($0.02), FiscalAI reports. Sono-Tek had a return on equity of 10.10% and a net margin of 9.32%. The company had revenue of $5.23 million during the quarter, compared to analysts’ expectations of $5.54 million.
Here are the key takeaways from Sono-Tek’s conference call:
- First-half results improved: Revenue rose 6% to approximately $10.9 million, gross margin expanded to 55% from 51%, operating income increased 41%, and net income grew 22%.
- Medical demand accelerated sharply, with sales up 289% to approximately $7.1 million as customers transitioned from development to commercial production of drug-eluting balloons, stents, and other medical devices.
- Sono-Tek received a record $7.19 million order for 10 alternative-energy production systems, adding to a medical diagnostic order exceeding $3.6 million; most of this more than $10.79 million in business is expected to ship in fiscal 2028.
- Management reiterated its expectation for flat to modest revenue growth in fiscal 2027, citing quarter-to-quarter volatility from the timing of large system shipments, while saying the recent orders improve visibility for fiscal 2028.
- The company plans to expand manufacturing capacity from roughly $27 million to $33 million–$36 million initially, with a potential later expansion to approximately $44 million–$45 million; initial capital spending is estimated at about $700,000.
Sono-Tek Trading Down 1.5%
Shares of SOTK stock opened at $6.11 on Friday. Sono-Tek has a 1-year low of $3.40 and a 1-year high of $7.48. The company has a market capitalization of $96.03 million, a price-to-earnings ratio of 50.92 and a beta of 0.07. The stock’s fifty day simple moving average is $5.35 and its 200-day simple moving average is $5.11.
Insider Transactions at Sono-Tek
In other Sono-Tek news, CFO Stephen Bagley sold 8,346 shares of the firm’s stock in a transaction dated Thursday, July 30th. The stock was sold at an average price of $5.13, for a total transaction of $42,814.98. Following the completion of the sale, the chief financial officer directly owned 21,254 shares in the company, valued at approximately $109,033.02. This trade represents a 28.20% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Over the last three months, insiders sold 13,000 shares of company stock valued at $67,666. 5.57% of the stock is currently owned by corporate insiders.
Sono-Tek News Roundup
Here are the key news stories impacting Sono-Tek this week:
- Positive Sentiment: Medical-market sales surged 209% year over year to $3.11 million in the quarter and 289% to $7.05 million for the first half, supporting Sono-Tek’s higher-value production systems strategy. Sono-Tek Fiscal Second Quarter and First Half 2027 Results
- Positive Sentiment: First-half revenue rose 6% to $10.89 million, while net income increased 22% to $1.11 million. Gross margin expanded to 55% for the first half, and operating income grew 41%.
- Positive Sentiment: Management reiterated its expectation for flat to modest fiscal 2027 revenue growth and said recent record orders improve visibility for fiscal 2028. The combined equipment and service backlog was $9.51 million, with approximately $7.19 million of subsequent orders expected to ship in fiscal 2028.
- Positive Sentiment: Sono-Tek outlined a facility expansion intended to raise manufacturing capacity to approximately $33 million-$36 million, with a longer-term plan to reach $44 million-$45 million. The company also ended the quarter with $17.7 million in cash, cash equivalents and marketable securities and no debt. Sono-Tek Facility Expansion
- Neutral Sentiment: The quarter’s revenue increased only 1% year over year to $5.23 million, reflecting the timing of several large orders and highlighting the company’s uneven near-term sales cadence.
- Negative Sentiment: Second-quarter earnings per share fell to $0.02 from $0.03 a year earlier, missing consensus estimates of roughly $0.04-$0.05. Revenue also missed expectations of approximately $5.54 million. Sono-Tek Misses Q2 Estimates
- Negative Sentiment: Net income declined to $366,294 from $423,693 despite higher gross profit, making the earnings miss the primary reason for the stock’s weaker reaction. Recent insider activity also showed sales rather than purchases by company executives.
Analyst Upgrades and Downgrades
Several research analysts have recently weighed in on SOTK shares. Weiss Ratings raised shares of Sono-Tek from a “hold (c+)” rating to a “buy (b)” rating in a research report on Thursday, October 8th. Wall Street Zen upgraded shares of Sono-Tek to a “strong-buy” rating in a research report on Sunday, July 12th. One equities research analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $8.50.
Read Our Latest Research Report on SOTK
Sono-Tek Company Profile
Sono-Tek Corporation develops and manufactures ultrasonic coating and precision liquid-deposition systems. Its technology uses high-frequency sound waves to atomize liquids into a controlled spray, enabling uniform application of coatings, adhesives, lubricants, and other materials while minimizing overspray and material waste.
The company’s products include ultrasonic spray nozzles, integrated coating systems, and customized solutions designed for automated manufacturing processes. Sono-Tek also provides application development, process optimization, installation, training, and technical support to help customers integrate its equipment into production lines.
Sono-Tek’s systems are used across a range of industries, including medical devices, electronics, semiconductor and advanced technology manufacturing, alternative energy, glass, textiles, and other industrial applications.
Read More
- Five stocks we like better than Sono-Tek
- Expecting a Market Correction? This Mega-Cap ETF Deserves a Spot on Your Watchlist
- ASML Can’t Keep Up With AI Demand—Why That’s a Good Thing
- Enovix’s 100,000-Battery Drone Order Sets Up a Test of Its Production Plans
- AMD’s Support Could Help Fermi Stock Overcome Its Biggest Hurdle
Receive News & Ratings for Sono-Tek Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sono-Tek and related companies with MarketBeat.com's FREE daily email newsletter.
